TABLE 2

Formation of lorcaserin N-carbamoyl glucuronide in human liver, kidney, intestine, and lung (smoker and nonsmoker) microsomes in the presence of 100 μM lorcaserin (substrate)

Experimental TissueLorcaserin N-Carbamoyl Glucuronide ± S.E.Foldless Compared with Liver Microsomes
pmol/mg protein/min
Liver1028.0 ± 21.6
Kidney185.9 ± 5.26-fold
Intestine133.1 ± 0.38-fold
Lung
    Smoker1.116 ± 0.060921-fold
    Nonsmoker0.493 ± 0.0702084-fold